Drug Pipeline

Dotinurad Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Phase 3
1
Top Sponsors
6
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-11 NCT07535034
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase…		 Trial sites expanded: 8 -> 17 locations
2026-05-23 NCT07535034
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase…		 Recruitment opened
2026-05-23 NCT07535034
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase…		 Trial sites expanded: 0 -> 8 locations
2026-05-21 NCT07089888
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout		 Trial sites expanded: 83 -> 86 locations
2026-05-14 NCT07089888
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout		 Trial sites expanded: 78 -> 83 locations
2026-05-14 NCT07089875
A Study of Dotinurad Versus Allopurinol in Participants With Gout		 Trial sites expanded: 95 -> 100 locations
Active Studies by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07089888 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout Tophaceous Gout Recruiting
NCT07089875 A Study of Dotinurad Versus Allopurinol in Participants With Gout Gout Recruiting
Phase 2
NCT07535034 A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase… Gout Recruiting
Sponsors Running Dotinurad Trials
Crystalys Therapeutics (3)
Get alerts when Dotinurad trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free